CDr10b inhibits the expression of cyclooxygenase-2 and inducible nitric oxide synthase induced by lipopolysaccharide.
Eur J Pharmacol
; 742: 42-6, 2014 Nov 05.
Article
em En
| MEDLINE
| ID: mdl-25196213
ABSTRACT
The pathophysiological processes of inflammation can lead to a host of diseases, such as periodontitis, atherosclerosis, rheumatoid arthritis, and even cancer. The dysregulated inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) activation play important roles in the development of certain inflammatory diseases. Here, we investigated the effects of CDr10b which is originally developed for a microglia staining probe on inflammation, by modulating NF-κB activation and iNOS and COX-2 expression induced by lipopolysaccharide (LPS) in murine macrophages. The CDr10b suppressed NF-κB activation and iNOS and COX-2 expression induced by LPS. All the results suggest that CDr10b is a promising novel agent for the treatment of inflammatory diseases.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Compostos de Boro
/
Lipopolissacarídeos
/
Ciclo-Oxigenase 2
/
Óxido Nítrico Sintase Tipo II
Limite:
Animals
Idioma:
En
Revista:
Eur J Pharmacol
Ano de publicação:
2014
Tipo de documento:
Article